Our research is focused on understanding the basic mechanisms that impact cellular behaviors and how these pathways become dysregulated in cancer. Importantly, we aim to translate these findings to outcomes that ultimately benefit patients. In particular, we are interested in pathways that convey information from the extracellular environment and instruct cells to stop proliferating. We employ a host of molecular and model-based approaches to studying these pathways with a focus on diseases such as Neurofibromatosis Type 2 (NF2) and non-small cell lung cancer (NSCLC). Please follow the link below to learn more about our research.

​